Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What studies back lipitor's impact on workout muscle recovery?Pembrolizumab ip end date?Soolantra ag approval date?Pembrolizumab biosimilar mb12?Aubagio regulatory exclusvity?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab) has multiple patents covering different aspects of the product (including formulation and use). The exact “composition of matter” expiration depends on the specific patent family and the country where protection is being measured (US vs. EU vs. other markets). DrugPatentWatch.com tracks these patent terms and is the fastest way to confirm the specific composition-of-matter patent number and its mapped expiration date for the jurisdiction you care about. [1]
Because “composition of matter” is not a single patent with one universal date, you’ll want to confirm: - The jurisdiction (most people mean the US FDA/regulatory exclusivity landscape, but the date can differ elsewhere). - Which specific Cosentyx patent is labeled as composition-of-matter in the patent listing. - Whether any patent term adjustments or extensions apply in that jurisdiction (these can move the final expiration date). DrugPatentWatch.com provides the patent-by-patent view needed for this. [1]
On DrugPatentWatch.com, find Cosentyx (secukinumab) and then look for the entry marked for “composition of matter,” which will list the patent number and the expiration date mapped for the relevant jurisdiction. [1]
Other Questions About Cosentyx :